stockrow
Saturday 7 November 2026
Export BSEM’s income statement to Excel — free account
BioStem Technologies, Inc.
BSEM Healthcare Biotechnology
- Revenue
- −28.0%
- EPS
- −86,766.7%
Quarter to June 2026, against a year earlier
1.13
0.09
+8.65%
Follow BSEM
Alert me
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
P/E ratio |
0.00 | 6.85 | 15.45 |
P/S ratio |
0.61 | 0.75 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | 0.00 |
P/B ratio |
1.63 | 0.00 | 0.00 |
Price to Tangible BV |
1.65 | 0.00 | 0.00 |
EV/Sales |
0.33 | 0.75 | 0.00 |
EV/EBITDA |
0.37 | 0.75 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 |
EV/FCF |
0.00 | 0.00 | 0.00 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | |
| 0.00% | 0.00% | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 |
Earnings Yield |
(9.17%) | 14.60% | 6.47% |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% |
Revenue per Share |
2.84 | 18.44 | 1.22 |
Operating CF per Share |
0.00 | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 |
EV/EBIT |
0.37 | 0.75 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.68 | 0.75 | 0.00 |
| Other line items | |||
Asset Turnover |
0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.00 | 0.00 | 0.00 |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.53 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 |
Average Assets |
0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 2 Nov 2026